Source: Business Wire Monday, June 17, 2013 12:09 PM IST (06:39 AM GMT) Editors: General: Consumer interest, People; Business: Business services, Healthcare, biotechnology & pharmaceutical; Healthcare (BW)(CELGENE)(CELG) Oral Anti-Cancer Therapy REVLIMID® (lenalidomide) Now Indicated...

More